Overactive Bladder Syndrome Clinical Trial
Official title:
Effect of Pelvic Floor Exercises Versus Pelvic Floor Exercises and Acupuncture on Overactive Bladder
The aim of this study is to investigate the effect of pelvic floor exercises augmented with acupuncture on overactive bladder
Status | Recruiting |
Enrollment | 40 |
Est. completion date | February 1, 2024 |
Est. primary completion date | January 15, 2024 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 50 Years to 60 Years |
Eligibility | Inclusion Criteria: Patients with a clinical diagnosis of idiopathic OAB syndrome. Willingness to take part in the study protocol. Ability to complete outcome measures. Ability to give informed consent. Acupuncture not contra-indicated. Age:50-60 years. Vaginal delivery. -Parity:2-3times. Body mass index <35kg/m2. Exclusion Criteria: - - Evidence of other pathology that may be contributing to OAB symptoms i.e., urinary tract infection or a neurological condition. - Smoking. - Taking sedative and hypnotic drugs. |
Country | Name | City | State |
---|---|---|---|
Egypt | Faculty of physical therapy | Giza |
Lead Sponsor | Collaborator |
---|---|
Cairo University |
Egypt,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | 8 Items overative bladder questionnaire | : The OAB-V8 asks how bothered one is by the 4 hallmark symptoms of OAB: urinary frequency, urgency, nocturia, and urge incontinence Patients respond on a 6-point Likert scale ranging from 0 (not at all) to 5 (a very great deal), with a maximum possible score of 40. After completing the awareness tool, patients were asked to calculate their scores by adding their responses . | 12 weeks | |
Other | 3days bladder diary test | It consists of three sheets to be completed by the patient (one for each day) and one evaluation sheet to be completed by the clinician based on the interpretation of the three patient-completed sheets. The patient should record, on the daily sheet, the time they wake up and go to bed and the time and volume of every micturition. | 12 weeks | |
Primary | Modified Oxford scale | The scale ranges from 0 to 5 ranging from "no contraction" to "maximal contraction which is assessed by digital palpation using 1 to 2 fingers inserted into the vagina or rectum . This method is reliable to assess improvements in overall function and voluntary control of the PFM necessary for proper voiding | 12 weeks | |
Secondary | patient perception of intensity and urgency scale (PPIUS) | A 5-point scale designed for measurement of both urinary urgency and urge incontinence. It has been incorporated into a micturition diary and has been used in OAB clinical trials | 12 WEEKS |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02540707 -
Comparisons of the Effects of Solifenacin Versus Mirabegron on Autonomic System, Arterial Stiffness and Psychosomatic Distress and Clinical Outcomes
|
Phase 4 | |
Not yet recruiting |
NCT05977634 -
Transcutaneous Tibial Nerve Stimulation for Idiopathic Overactive Bladder
|
N/A | |
Not yet recruiting |
NCT06438861 -
Role of Combination Therapy in Women With Refractory Overactive Bladder
|
N/A | |
Completed |
NCT01114412 -
Basic Sensations Coming From the Bladder
|
||
Recruiting |
NCT06045728 -
Telerehabilitation for Overactive Bladder Syndrome in Obese Women
|
N/A | |
Recruiting |
NCT03952299 -
Oxybutynin for Post-surgical Bladder Pain and Urgency
|
Phase 3 | |
Active, not recruiting |
NCT03758235 -
Overactive Bladder Syndrome: Incobotulinumtoxin Versus Onabotulinumtoxin
|
Phase 3 | |
Completed |
NCT01912885 -
Comparison of Posterior Tibial Nerve Electrical Stimulation Protocols for Overactive Bladder Syndrome
|
N/A | |
Completed |
NCT04300400 -
Treatment of the Overactive Bladder Syndrome: A Delphi Study
|
||
Recruiting |
NCT04982120 -
Use of Repris Needle in Bladder Injection
|
N/A | |
Completed |
NCT06123364 -
Extracorporeal Magnetic Innervation in Combination With Mirabegron in the Treatment of Overactive Bladder
|
N/A | |
Recruiting |
NCT05221021 -
Vaginal Estradiol vs Oral Beta-3 Agonist for Overactive Bladder Syndrome
|
Phase 4 | |
Terminated |
NCT04256876 -
TTNS Versus Sham Therapy for Children With iOAB (TaPaS Part I)
|
N/A | |
Not yet recruiting |
NCT03331081 -
Effects of Bladder Training and Pelvic Floor Muscle Training on the Symptomatology of Overactive Bladder Syndrome
|
N/A | |
Recruiting |
NCT04873037 -
BTL Emsella Chair Versus Sham for the Treatment of Overactive Bladder
|
N/A | |
Completed |
NCT02024945 -
Efficacy, Tolerability and Impact on Quality of Life of Propiverine in Patients With Overactive Bladder Syndrome
|
Phase 4 | |
Completed |
NCT00546637 -
Fesoterodine "add-on" Male Overactive Bladder Study
|
Phase 3 | |
Not yet recruiting |
NCT06143397 -
Effect of TTNS and PNS on Neurogenic Overactive Bladder Symptoms in Female Patients With Multiple Sclerosis.
|
N/A | |
Recruiting |
NCT03044912 -
Therapeutic Efficacy and Safety of Mirabegron Treatment on Patients With Overactive Bladder Syndrome in Taiwan
|
Phase 3 | |
Recruiting |
NCT03817203 -
Effects of Kinesio Taping Application in Women With Overactive Bladder
|
N/A |